Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass
journal contribution
posted on 2023-05-25, 23:05authored byAdams, MJ, Cardigan, RA, Marchant, WA, Grocott, MPW, Mutch, M, Prudy, G, Mackie, IJ, Machin, SJ
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin and observe any association with increased risk of excessive coagulation activation, morbidity, or mortality.
History
Publication title
Journal of Cardiothoracic and Vascular Anesthesia
Volume
16
Article number
1
Number
1
Pagination
59
ISSN
1053-0770
Publication status
Published
Rights statement
The definitive version is available at http://www.sciencedirect.com